Thomas Wilson Eastling

Insider Reports History

Location
San Diego, CA
Signature
/s/ Ruoyu Chen, as attorney-in-fact for Thomas Eastling
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas Wilson Eastling:

Company Role Class Num Shares Value Price $ Report Date Ownership
GYRE THERAPEUTICS, INC. Director Common Stock 15,000 $103,950 $6.93 16 Apr 2025 Direct
GYRE THERAPEUTICS, INC. Director Stock Option (Right to Buy) 26,000 04 Jun 2025 Direct

Insider Reports Filed by Thomas Wilson Eastling

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GYRE GYRE THERAPEUTICS, INC. 04 Jun 2025 1 $0 4 Director 06 Jun 2025, 16:22
GYRE GYRE THERAPEUTICS, INC. 16 Apr 2025 2 +$103,950 4 Director 18 Apr 2025, 17:27
GYRE GYRE THERAPEUTICS, INC. 14 Aug 2024 1 $0 4 Director 16 Aug 2024, 20:58
GYRE GYRE THERAPEUTICS, INC. 31 Oct 2023 2 $0 4 Director 01 Nov 2023, 06:15
GYRE CATALYST BIOSCIENCES, INC. 26 Dec 2022 0 $0 3 Director 05 Jan 2023, 15:06